(Q30368453)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18366525%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

Influenza A/H5N1 infection: other treatment options and issues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18366525%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18366525%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

David S C Hui

series ordinal

1

1 reference

21 June 2017

publication date

1 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18366525%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18366525%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

13 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18366525%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

S22-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18366525%20AND%20SRC:MED&resulttype=core&format=json

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Strategies for mitigating an influenza pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Avian influenza (H5N1): implications for intensive care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

The critically ill avian influenza A (H5N1) patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Protective ventilation of patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Comparison of two fluid-management strategies in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Re-emergence of fatal human influenza A subtype H5N1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Lethal avian influenza A (H5N1) infection in a pregnant woman in Anhui Province, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Noninvasive positive-pressure ventilation: An experimental model to assess air and particle dispersion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Pathology of fatal human infection associated with avian influenza A H5N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Human disease from influenza A (H5N1), Thailand, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Avian influenza A (H5N1) infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Avian influenza A (H5N1) in 10 patients in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Three Indonesian clusters of H5N1 virus infection in 2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Fatal aspergillosis in a patient with SARS who was treated with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Sepsis: a new hypothesis for pathogenesis of the disease process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Pandemic influenza: a potential role for statins in treatment and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Statins and the risk of pneumonia: a population-based, nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Cytotoxic therapy for severe avian influenza A (H5N1) infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Large artery ischaemic stroke in severe acute respiratory syndrome (SARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Respiratory infections during SARS outbreak, Hong Kong, 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Airflows around oxygen masks: A potential source of infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Exhaled air dispersion during oxygen delivery via a simple oxygen mask.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Airflow and droplet spreading around oxygen masks: a simulation model for infection control research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Protecting staff against airborne viral particles: in vivo efficiency of laser masks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Protecting healthcare staff from severe acute respiratory syndrome: filtration capacity of multiple surgical masks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Issues relevant to the adoption and modification of hospital infection-control recommendations for avian influenza (H5N1 infection) in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Modified N95 mask delivers high inspired oxygen concentrations while effectively filtering aerosolized microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

Avian influenza virus (H5N1): a threat to human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01250.X

10.1111/J.1440-1843.2008.01250.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18366525%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference